Brief: Evaxion Announces Promising Clinical Phase 1 Data For Its Personalized Cancer Vaccine Evx-01
25/05/2023 23:19
Evaxion Biotech A/S EVAX.O :
* EVAXION ANNOUNCES PROMISING CLINICAL PHASE 1 DATA FOR ITS
PERSONALIZED CANCER VACCINE EVX-01
* EVAXION BIOTECH A/S - STUDY MET PRIMARY ENDPOINTS FOR
TOLERABILITY AND SAFETY
Source text for Eikon: ID:
Further company coverage: EVAX.O
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma